ECCC joins major national cooperative cancer clinical trials group
The Edwards Comprehensive Cancer Center has been accepted as a member of the North Central Cancer Treatment Group (NCCTG), a prestigious cancer research network that will give Huntington/Tri-State cancer patients access to even more promising new cancer therapies. Because of this membership, the ECCC will soon be able to offer cancer patients Phase I-III clinical trials involving various tumor sites such as breast, gastrointestinal, lung and other malignancies from this major cooperative group.
Dr. Maria Tria Tirona, a medical oncologist at the ECCC and principal investigator for the NCCTG at the Edwards Comprehensive Cancer Center, said she hopes the clinical trials that come through this membership will be offered in the future to patients throughout West Virginia.
The North Central Cancer Treatment Group (NCCTG), working with Mayo Clinic to bring the latest cancer research to the community, was founded in 1977 by pioneering physicians from the north central region of the United States and the Mayo Clinic in Rochester, Minn. These physicians saw a need to bring high-quality cancer care and research to the communities where patients live and receive most of their medical care. To achieve this goal, they formed a cancer clinical trials cooperative group. This cooperative group allows promising scientific ideas developed at Mayo Clinic to be tested in many communities throughout the NCCTG network, allowing broad access to the latest therapies.
Click here for information about clinical trials available at the ECCC or call 304-399-6617.
- Last updated: 03/16/2011
